title: Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease.
authors.affiliation: Neurology Department, Geneva University Hospitals and Medical School, Switzerland.
authors.forename: C
authors.initials: C
authors.lastname: Pot
authors.forename: R
authors.initials: R
authors.lastname: Oppliger
authors.forename: V
authors.initials: V
authors.lastname: Castillo
authors.forename: A
authors.initials: A
authors.lastname: Coeytaux
authors.forename: C
authors.initials: C
authors.lastname: Hauser
authors.forename: P R
authors.initials: PR
authors.lastname: Burkhard
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001058:Apomorphine / Q000009:adverse effects* / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000139:chemically induced*; D008875:Middle Aged; D015434:Panniculitis / Q000139:chemically induced*; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D001058:Apomorphine